| Product Code: ETC7643873 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland mRNA Vaccine and Therapeutics Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland mRNA Vaccine and Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland mRNA Vaccine and Therapeutics Market - Industry Life Cycle |
3.4 Ireland mRNA Vaccine and Therapeutics Market - Porter's Five Forces |
3.5 Ireland mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Ireland mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Ireland mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 Ireland mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Ireland mRNA Vaccine and Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development for mRNA vaccine technology |
4.2.2 Growing prevalence of infectious diseases and chronic conditions in Ireland |
4.2.3 Government initiatives and support for vaccination programs |
4.3 Market Restraints |
4.3.1 High costs associated with mRNA vaccine development and production |
4.3.2 Regulatory challenges and approval processes for new therapeutics |
4.3.3 Limited manufacturing capacity for mRNA vaccines in Ireland |
5 Ireland mRNA Vaccine and Therapeutics Market Trends |
6 Ireland mRNA Vaccine and Therapeutics Market, By Types |
6.1 Ireland mRNA Vaccine and Therapeutics Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland mRNA Vaccine and Therapeutics Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Ireland mRNA Vaccine and Therapeutics Market Revenues & Volume, By Self-amplifying mRNA-based Vaccines, 2021- 2031F |
6.1.4 Ireland mRNA Vaccine and Therapeutics Market Revenues & Volume, By Conventional Non-amplifying mRNA-based Vaccines, 2021- 2031F |
6.2 Ireland mRNA Vaccine and Therapeutics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland mRNA Vaccine and Therapeutics Market Revenues & Volume, By Cancer, 2021- 2031F |
6.2.3 Ireland mRNA Vaccine and Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.4 Ireland mRNA Vaccine and Therapeutics Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F |
6.2.5 Ireland mRNA Vaccine and Therapeutics Market Revenues & Volume, By Other, 2021- 2031F |
6.3 Ireland mRNA Vaccine and Therapeutics Market, By Treatment Type |
6.3.1 Overview and Analysis |
6.3.2 Ireland mRNA Vaccine and Therapeutics Market Revenues & Volume, By Monoclonal Antibody, 2021- 2031F |
6.3.3 Ireland mRNA Vaccine and Therapeutics Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.3.4 Ireland mRNA Vaccine and Therapeutics Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.3.5 Ireland mRNA Vaccine and Therapeutics Market Revenues & Volume, By Other, 2021- 2031F |
6.4 Ireland mRNA Vaccine and Therapeutics Market, By End user |
6.4.1 Overview and Analysis |
6.4.2 Ireland mRNA Vaccine and Therapeutics Market Revenues & Volume, By Research Laboratories and Organizations, 2021- 2031F |
6.4.3 Ireland mRNA Vaccine and Therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 Ireland mRNA Vaccine and Therapeutics Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.5 Ireland mRNA Vaccine and Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland mRNA Vaccine and Therapeutics Market Import-Export Trade Statistics |
7.1 Ireland mRNA Vaccine and Therapeutics Market Export to Major Countries |
7.2 Ireland mRNA Vaccine and Therapeutics Market Imports from Major Countries |
8 Ireland mRNA Vaccine and Therapeutics Market Key Performance Indicators |
8.1 Research funding allocated towards mRNA vaccine development |
8.2 Number of clinical trials for mRNA therapeutics conducted in Ireland |
8.3 Adoption rate of mRNA vaccines in the Irish population |
9 Ireland mRNA Vaccine and Therapeutics Market - Opportunity Assessment |
9.1 Ireland mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Ireland mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Ireland mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.4 Ireland mRNA Vaccine and Therapeutics Market Opportunity Assessment, By End user, 2021 & 2031F |
10 Ireland mRNA Vaccine and Therapeutics Market - Competitive Landscape |
10.1 Ireland mRNA Vaccine and Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Ireland mRNA Vaccine and Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here